Is iQiyi Really the Netflix of China, And Is It a Buy?

It was a name that we found early, allowing us to nab IQ stock in the low-$20s. Anyway, maybe investors are now wondering whether iQiyi stock is a buy at current levels. After its huge rise, IQ stock has come back to earth and has been basing in the $26 to $28 range.

Gabelli says the US is 'finally' putting money into defen...

Traders Josh Brown, Jim Lebenthal, Stephanie Link and Jon Najarian are joined by Mario Gabelli, chairman and CEO of Gamco Investors, to discuss the record rally in the markets.

• 
  Why Mario Gabelli thinks you should own CBS and Viacom

  CNBC Videos
• 
  Mario Gabelli's final trade: GCP Applied Technologies

  CNBC Videos

A $10 billion marijuana producer just spun off its venture arm in the hopes it will become the 'Google Ventures of cannabis' (RIV)

Canopy Rivers, the venture-capital arm of Canopy Growth, made its debut on the Toronto Stock Exchange Thursday morning at $18.44 per share. The company, which makes minority investments in burgeoning marijuana companies, in an attempt to become the "Google Ventures of cannabis," found its way onto the exchange via a reverse takeover with a company formerly known as AIM2 Ventures.

• 
  Don’t Get Too Excited About Coca-Cola’s “Cannabis Drink” Buzz

  Motley Fool
• 
  Marijuana Stocks Hope This Will Make Their Shareholders Rich

  Motley Fool

For bold Chinese buyers of soybeans, bargain U.S. prices trump trade war

XIAN/BEIJING (Reuters) - At least two cargoes of U.S. soybeans are heading for China as some buyers are willing to risk taking up historically cheap U.S. beans even amid worries that Beijing may take further steps to deter imports amid mounting trade tensions with Washington. Grain traffic from the United States to China has nearly ground to a halt since Beijing hit $50 billion in U.S. imports, including soybeans, with hefty tariffs, in retaliation for a similar move by Washington. The buyers of the beans, which are used to make meal for animal feed and oil for cooking, are not known, and the cargoes may have been booked before the tariffs were introduced.

• 
  BNEF Brief: SunPower Wins Tariff Exemption

  Bloomberg
• 
  Receding Risk Aversion Drives Dollar Lower Against Most Major Currencies

  FX Empire

The new ‘Tilray’ marijuana stock is here — this is how to set up the trade

The 11 pointers I recently gave to investors to carefully make money in marijuana stocks have generated a lot of interest. In some ways, Denver-based New Age Beverages is the new Tilray. Tilray has been the most explosive marijuana stock.

Alibaba (BABA) Dips More Than Broader Markets: What You Should Know

Investors will be hoping for strength from BABA as it approaches its next earnings release, which is expected to be November 1, 2018. In that report, analysts expect BABA to post earnings of $1.25 per share. It is also important to note the recent changes to analyst estimates for BABA.

• Zacks: Brokerages Expect Cadence Design Systems Inc (CDNS) to Post $0.41 Earnings Per Share

  The Cerbat Gem
• $1.15 Earnings Per Share Expected for Synaptics, Incorporated (SYNA) This Quarter

  The Cerbat Gem

How to Create a Durable Estate Plan

Christine Benz offers ways to keep your financial plan intact as retirement draws close.

Upcoming Earnings to Watch: NKE, RAD, BB

Investors are still looking with a cautious eye toward next week’s Fed meeting, but with Q3 earnings season on the horizon, it is possible a thaw in the trade war could give way to further gains. The memory chip giant beat earnings estimates and posted decent profit guidance, but investors were not impressed. With that said, investors can always prepare for these events with the Zacks Earnings Calendar.

5 Top Stock Trades for Monday — Time to Finally Buy Starbucks?

As wages grow and inflation remains tame, this could give the retail sector the boost investors have been waiting for. Names like Target (NYSE:TGT), TJX Companies (NYSE:TJX), Home Depot (NYSE:HD) and others have helped to push the SPDR Retail ETF (NYSEARCA:XRT) higher. As for the ETF, it’s move above $51 resistance was important, as this level has become a key level of support going into the all-important second half.

Weekend roundup: Marijuana becomes bitcoin | How investing fads work | Short squeeze candidates

Move over bitcoin and ilk: Shares of Canadian marijuana companies went through the roof this week after the U.S. Drug Enforcement Administration approved Tilray’s plan to import a medical cannabis product. The ETFMG Alternative Harvest ETF (MJ) — which holds many Canadian marijuana stocks — was up 22% for one week through Thursday.

• 
  Don’t Get Too Excited About Coca-Cola’s “Cannabis Drink” Buzz

  Motley Fool
• 
  Canopy Growth CEO expects US pot market to open up eventually

  CNN Money

All pot stocks aren’t Tilray — and that’s a good thing, says CEO of rival Canopy Growth

Investors shouldn’t let pot stock Tilray Inc.’s (TLRY) wild trading week turn them off from the marijuana sector, rival cannabis concern Canopy Growth Corp. (CGC)  CEO Bruce Linton said on CNBC Friday. The fledgling sector is much more stable than Tilray’s headlines would imply, Linton insists, after Nasdaq had to halt Tilray trading five times during Wednesday’s session. This means Tilray is not the sector proxy that Wall Street makes it out to be, Linton argued.

• 
  Canopy Growth CEO on Tilray, company growth and the futur...

  CNBC Videos
• 
  Canopy Growth CEO expects US pot market to open up eventually

  CNNMoney

Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status

Pfizer, Inc. PFE announced that it has received Breakthrough Therapy designation for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, from the FDA. The designation was granted on the basis of positive immunogenicity data from a phase II study of the multivalent pneumococcal conjugate vaccine in adults aged 60 to 64 years. Pfizer’s stock has outperformed the industry this year so far.